Karuna Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (11)

View All

Latest Posts

About This Stock More About This Stock
ABBV: This Top Biotech Just Went On A Buying Spree
Article By: Tony Daltorio
Thursday, January 25, 2024 7:00 AM EDT
AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel).
In this article: ABBV Also: IMGN, AMGN, CERE, KRTX
Read
Opportunities In Large Cap Growth And Small Cap
Article By: Herbert Blank
Thursday, October 20, 2022 10:03 AM EDT
The third quarter was true "a tale of two eighths." It was a clear dichotomy starting with a bull market rally and ending with the bear mauling at the end of August and all of September.
In this article: GTLS, QQQ, IWD, IWF, IWM, MDY, SPY, VOO, SWAV, KRTX
Read
Biotech Stocks Well-Positioned For The Fourth Quarter
Article By: Tarun Chandra, CFA
Wednesday, October 12, 2022 1:12 AM EDT
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
In this article: NVO, PFE, AMGN, BIIB, CCXI, BLUE, GBT, RYTM, KRTX, FMTX, AKRO
Read
Week In Review: Zai Lab Announces Two In-Licensings With Total Value Of $800 Million
Article By: ChinaBio® Today
Saturday, November 13, 2021 2:15 PM EDT
Shanghai Zai Lab announced two major in-licensings: a $615 million deal for two cancer drugs from Blueprint Medicines and a $187 million agreement for a psychiatric drug from Karuna Therapeutics.
In this article: 600566.SS, BPMC, ZLAB, KRTX, IMAB, 1672.HK, 9966.HK, 1952.HK, 326030.KS
Read
Biotechs Ready To Roar
Article By: Tarun Chandra, CFA
Sunday, June 13, 2021 11:15 AM EDT
The recent FDA decision will reverberate across the industry and the healthcare sector for many reasons.
In this article: BIIB Also: LLY, IBB, XBI, XLV, SUPN, ITCI, BHVN, DNLI, SAVA, KRTX, ARVN, ANVS, INMB, AVXL, PRTA
Read
All Posts

Latest Tweets for $KRTX

No tweets yet!

PARTNER HEADLINES